286 related articles for article (PubMed ID: 29568203)
1. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions.
Zekri AN; El Deeb S; Bahnassy AA; Badr AM; Abdellateif MS; Esmat G; Salama H; Mohanad M; El-Dien AE; Rabah S; Abd Elkader A
World J Gastroenterol; 2018 Mar; 24(11):1228-1238. PubMed ID: 29568203
[TBL] [Abstract][Full Text] [Related]
2. The Expression of ILT4 in Myeloid Dendritic Cells in Patients with Hepatocellular Carcinoma.
Wang L; Fan J; Ye W; Han J; Zhang Y; Zhao L; Duan J; Yin D; Yi Y
Immunol Invest; 2019 Oct; 48(7):704-718. PubMed ID: 31044626
[TBL] [Abstract][Full Text] [Related]
3. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression.
Zekri AR; Ashour MS; Hassan A; Alam El-Din HM; El-Shehaby AM; Abu-Shady MA
World J Gastroenterol; 2005 Nov; 11(42):6624-30. PubMed ID: 16425355
[TBL] [Abstract][Full Text] [Related]
4. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.
Kakumu S; Ito S; Ishikawa T; Mita Y; Tagaya T; Fukuzawa Y; Yoshioka K
J Gastroenterol Hepatol; 2000 Apr; 15(4):431-6. PubMed ID: 10824889
[TBL] [Abstract][Full Text] [Related]
5. The Putative Role of Natural Killer Cells in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
Hassouna MM; Radwan EM; Abdelsameea E; Estaphan S; Abd Elrhman HE; Abdel-Samiee M; Naguib M
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2559-2567. PubMed ID: 34452571
[TBL] [Abstract][Full Text] [Related]
6. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
[TBL] [Abstract][Full Text] [Related]
7. [Phenotype and function of myeloid dendritic cells pulsed with hepatitis B virus antigens in patients with HBV-associated hepatocellular carcinoma].
Qian S; Shi M; Zhang H; Zhang B; Xu DP; Wang FS
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):248-52. PubMed ID: 15854486
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.
Tsunematsu H; Tatsumi T; Kohga K; Yamamoto M; Aketa H; Miyagi T; Hosui A; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Int J Cancer; 2012 Jan; 130(2):356-64. PubMed ID: 21351090
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease.
Kakumu S; Okumura A; Ishikawa T; Yano M; Enomoto A; Nishimura H; Yoshioka K; Yoshika Y
Clin Exp Immunol; 1997 Sep; 109(3):458-63. PubMed ID: 9328122
[TBL] [Abstract][Full Text] [Related]
10. The expression and function of immunoglobulin-like transcript 4 in dendritic cells from patients with hepatocellular carcinoma.
Fan J; Han J; Li J; Gu A; Yin D; Song F; Wang L; Yi Y
Hum Immunol; 2020 Dec; 81(12):714-725. PubMed ID: 33228921
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of Human Hepatic Intrasinusoidal CD56
Hwang S; Han J; Baek JS; Tak E; Song GW; Lee SG; Jung DH; Park GC; Ahn CS; Kim N
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925759
[TBL] [Abstract][Full Text] [Related]
12. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
13. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma.
Kim MJ; Jang JW; Oh BS; Kwon JH; Chung KW; Jung HS; Jekarl DW; Lee S
Cytokine; 2013 Nov; 64(2):516-22. PubMed ID: 24035756
[TBL] [Abstract][Full Text] [Related]
14. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
15. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
Lee Y; Park US; Choi I; Yoon SK; Park YM; Lee YI
Clin Cancer Res; 1998 Jul; 4(7):1711-7. PubMed ID: 9676846
[TBL] [Abstract][Full Text] [Related]
16. Expression of Hu-IFN-alphaR2 chain of type I interferon receptor in human hepatocellular carcinoma and non-cancerous tissues.
Takayama A; Yano H; Ogasawara S; Higaki K; Kojiro M
Int J Mol Med; 2000 Dec; 6(6):621-7. PubMed ID: 11078820
[TBL] [Abstract][Full Text] [Related]
17. Effects of pulsing procedure of interleukin-12 in combination with interleukin-2 on the activation of peripheral blood lymphocytes derived from patients with hepatocellular carcinoma.
Sawayama T; Sakaguchi K; Senoh T; Ohta T; Nishimura M; Takaki A; Tsuji T; Shiratori Y
Acta Med Okayama; 2003 Dec; 57(6):285-92. PubMed ID: 14726965
[TBL] [Abstract][Full Text] [Related]
18. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
[TBL] [Abstract][Full Text] [Related]
19. [Identification of immunological effector cells after autologous cytokine-induced killer cells treatment and its clinical implication in hepatocellular carcinoma patients].
Shi M; Zhang B; Tang ZR; Lei ZY; Wang HF; Feng YY; Liu JC; Fan ZP; Li HW; Mu JS; Wang FS
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2049-53. PubMed ID: 14703414
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma.
Kohga K; Tatsumi T; Tsunematsu H; Aono S; Shimizu S; Kodama T; Hikita H; Yamamoto M; Oze T; Aketa H; Hosui A; Miyagi T; Ishida H; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Cancer Immunol Immunother; 2012 Sep; 61(9):1425-32. PubMed ID: 22302133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
